An analysis of the Australian Therapeutic Goods Administration Database of Adverse Event Notifications of diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitors in surgical patients

Anaesth Intensive Care. 2020 Jan;48(1):70-72. doi: 10.1177/0310057X19892988. Epub 2020 Jan 19.
No abstract available

Publication types

  • Letter

MeSH terms

  • Australia
  • Diabetes Mellitus, Type 2*
  • Diabetic Ketoacidosis*
  • Humans
  • Hypoglycemic Agents
  • Professionalism
  • Sodium-Glucose Transporter 2 Inhibitors* / adverse effects

Substances

  • Hypoglycemic Agents
  • Sodium-Glucose Transporter 2 Inhibitors